Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine weather Remegal in fixed dosage 1500 mg/daily is
effictive and safe in patients with epilepsy with partial seizures